NI
INFI

Numeric Investors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Numeric Investors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$126K Sell
62,000
-3,400
-5% -$7.05K ﹤0.01% 1039
2017
Q3 		$87K Sell
65,400
-55,455
-46% -$68.9K ﹤0.01% 1048
2017
Q2 		$190K Hold
120,855
– – ﹤0.01% 986
2017
Q1 		$390K Sell
120,855
-659,044
-85% -$1.62M ﹤0.01% 846
2016
Q4 		$1.05M Buy
779,899
+19,000
+2% +$24.8K 0.01% 648
2016
Q3 		$1.19M Sell
760,899
-82,924
-10% -$127K 0.01% 577
2016
Q2 		$1.12M Buy
843,823
+738,269
+699% +$3.45M 0.01% 551
2016
Q1 		$556K Sell
105,554
-1,084,512
-91% -$6.64M 0.01% 687
2015
Q4 		$9.34M Buy
1,190,066
+1,008,867
+557% +$8.69M 0.1% 204
2015
Q3 		$1.53M Sell
181,199
-893,941
-83% -$8.25M 0.02% 450
2015
Q2 		$11.8M Buy
1,075,140
+390,400
+57% +$5.01M 0.14% 149
2015
Q1 		$9.57M Buy
684,740
+283,342
+71% +$4.33M 0.12% 182
2014
Q4 		$6.78M Buy
401,398
+377,999
+1,615% +$5.5M 0.09% 195
2014
Q3 		$314K Buy
+23,399
New +$279K ﹤0.01% 682
2013
Q4 		– Sell
-71,400
Closed -$1.25M – 909
2013
Q3 		$1.25M Buy
71,400
+4,700
+7% +$90K 0.02% 405
2013
Q2 		$1.08M Buy
+66,700
New +$2.06M 0.02% 400

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Numeric Investors's INFI Position: Q4 2017 in Review

Numeric Investors reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 5.2% in Q4 2017, selling an estimated $7.05K and leaving 62,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Numeric Investors first reported a position in INFI in Q2 2013 and has held it in 16 quarters since. The position peaked at $11.8M in Q2 2015. 65 funds tracked by Wall St. Rank hold INFI as of Q4 2017.

  • Numeric Investors held 62,000 shares of Infinity Pharmaceuticals, Inc. worth $126K as of Q4 2017.
  • Numeric Investors sold 3,400 Infinity Pharmaceuticals, Inc. shares in Q4 2017, an estimated $7.05K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1039 holding.
  • Numeric Investors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 16 quarters since.
  • Numeric Investors's Infinity Pharmaceuticals, Inc. position peaked at $11.8M in Q2 2015.
  • 65 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.